ZeZentalis Pharma

Forecast & Rating9 analysts currently cover ZeZentalis Pharma, with about 44.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $6.89, about 89.8% upside from the current price of $3.63. Price targets range from $4.00 to $10.00 — a wide spread, showing clear disagreement over just how much ZeZentalis Pharma can rise. Historically, about 22.2% of past price targets were eventually met, which adds credibility. For you, this means institutional views on ZeZentalis Pharma are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 12, 2026; for reference only and not investment advice.